We are live on ! Find out more
ACP

Acuta Capital Partners Portfolio holdings

AUM $142M
1-Year Est. Return 783.79%
This Fund
S&P 500
This Quarter Est. Return
+22.26%
1 Year Est. Return
+783.79%
3 Year Est. Return
+7,472.18%
5 Year Est. Return
+13,792.16%
10 Year Est. Return
+1,629,663.73%
AUM
$148M
AUM Growth
–
Cap. Flow
+$132M
Cap. Flow %
89.25%
Top 10 Hldgs %
53.27%
Holding
64
New
62
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
FOLD
Amicus Therapeutics
FOLD
+$11.2M
2
PTX
Pernix Therapeutics Holdings, Inc.
PTX
+$5.76M
3
ALIM
Alimera Sciences
ALIM
+$5.72M
4
BEAT
BioTelemetry, Inc.
BEAT
+$4.15M
5
LMAT icon
LeMaitre Vascular
LMAT
+$3.31M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 47.62%
2 Consumer Discretionary 1.43%
3 Financials 1.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NSPH
51
DELISTED
NANOSPHERE INC. COM NEW
NSPH
$571K 0.39%
+72,844
New +$680K
CEMI
52
DELISTED
Chembio diagnostics, Inc.
CEMI
$571K 0.39%
+146,099
New +$605K
EYPT icon
53
EyePoint Inc
EYPT
$1.04B
$503K 0.34%
+12,234
New +$490K
NPSP
54
CALL
DELISTED
NPS PHARMACEUTICALS INC
NPSP
$358K 0.24%
+10,000
New +$299K
XNCR icon
55
Xencor
XNCR
$1.44B
$353K 0.24%
+22,011
New +$255K
OXM icon
56
Oxford Industries
OXM
$568M
$337K 0.23%
+24,742
New +$1.51M
NPSP
57
DELISTED
NPS PHARMACEUTICALS INC
NPSP
$286K 0.19%
+8,000
New +$239K
VCYT icon
58
Veracyte
VCYT
$3.58B
$280K 0.19%
+29,024
New +$227K
INSM icon
59
Insmed
INSM
$21.3B
$203K 0.14%
+13,154
New +$187K
TRIL
60
DELISTED
Trillium Therapeutics Inc.
TRIL
$171K 0.12%
+19,000
New +$148K
CYHHZ
61
DELISTED
Community Health Systems, Inc. Series A Contingent Value Rights
CYHHZ
$74K 0.05%
+2,963,721
New +$86.2K
ASMB icon
62
Assembly Biosciences
ASMB
$503M
$30K 0.02%
+317
New +$31.2K
1 2
3

Similar funds

EC
EJF Capital Arlington, Virginia $142M AUM 23.3% 1-Year Est. Return
YEPX
Yorktown Energy Partners XI New York $142M AUM 130.51% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
IA
IF Advisors San Antonio, Texas $141M AUM
MAM
Maytree Asset Management Hong Kong $141M AUM 114% 1-Year Est. Return
HA
HFG Advisors Cincinatti, Ohio $142M AUM 16.9% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $141M AUM 190.82% 1-Year Est. Return
KCAM
Kagan Cocozza Asset Management Mickleton, New Jersey $142M AUM 12.02% 1-Year Est. Return

Acuta Capital Partners's Q4 2014 Portfolio in Review

Q4 2014 is the first quarter with a 13F filing on record for Acuta Capital Partners, which disclosed 64 positions worth $148M. Its ten largest holdings account for 53% of the portfolio.

Its largest position is Amicus Therapeutics: 1,632,720 shares worth $13.6M.

By sector, the portfolio is most concentrated in Healthcare at 48% of assets, followed by Consumer Discretionary and Financials.

  • Acuta Capital Partners's largest Q4 2014 buy was Amicus Therapeutics: 1,632,720 shares worth $13.6M.
  • Acuta Capital Partners's ten largest holdings make up 53% of its $148M portfolio in Q4 2014.
  • Acuta Capital Partners disclosed 64 positions in Q4 2014, its first 13F filing on record.

Based on Acuta Capital Partners's 13F filing for Q4 2014, filed 13 Feb 2015.